Article

Public's awareness of eye disease needed, according to New York State survey

A survey conducted by the New York State Department of Health, with the support of the American Academy of Ophthalmology shows a need to educate the public on the risk of eye disease.

Washington, DC-A survey conducted by the New York State Department of Health, with the support of the American Academy of Ophthalmology (AAO) shows a need to educate the public on the risk of eye disease.

Data analysis of the study, conducted in 2006, was recently released and was based on a telephone survey of 4,258 people aged 40 and older.

The health-related behavior study, Behavioral Risk Factor Surveillance System, asked vision-related questions-and New York was one of the first states to include this.

Key findings of the study show that one in six adults has distance vision impairment based on their ability to recognize a friend across the street. More than one-third of New Yorkers aged 40 and older have not visited an eye-care professional in the past year.

"This survey highlights the importance of educating New Yorkers about their risk for eye disease," said Diane J. Kraus, MD, president of the New York State Ophthalmological Society. "Even though you have no symptoms of eye disease, you can still be at risk for a potentially blinding disease. It's important to have a baseline eye disease screening in order to catch diseases before they damage your vision."

As a part of the AAO's Eye Smart Campaign, it recommends that adults with no signs or risk factors for eye disease get a baseline eye disease screening at age 40.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Mark Lobanoff, MD, on making the move to office-based surgery
Barsha Lal, PhD, discusses the way low dose atropine affects accommodative amplitude and dynamics at the 2025 ARVO meeting
(Image credit: Ophthalmology Times) NeuroOp Guru: When eye findings should prompt neuroimaging in suspected neuro-Behcet disease
At the Association for Research in Vision and Ophthalmology (ARVO) meeting, Katherine Talcott, MD, a retina specialist at Cleveland Clinic, shared her findings on EYP-1901 (EyePoint Pharmaceuticals) in the phase 2 DAVIO study.
Dr. Jogin Desai, founder of Eyestem Research, discusses his research at the Association for Research in Vision and Ophthalmology.
(Image credit: Ophthalmology Times) ASCRS 2025: Michael Rivers, MD, shares his takeaways as a panelist at the inaugural SightLine event
(Image credit: Ophthalmology Times) ASCRS 2025: Karl Stonecipher, MD, on LASIK outcomes using an aspheric excimer laser for high myopia
John Tan talks about an emergency triage framework for retinal artery occlusion at the 2025 Association for Research in Vision and Ophthalmology (ARVO) meeting.
Dr Robert Maloney at the 2025 Controversies in Modern Eye Care meeting
Wendy Lee, MD, MS, at Controversies in Modern Eye Care 2025.
© 2025 MJH Life Sciences

All rights reserved.